Verge HealthTech Fund

www.verge.fund

VCMatch tracks Verge HealthTech Fund as an investor focused on Digital Health, Medtech, and AI/ML companies, Seed and Series A rounds, and Global, Bangladesh, and Taiwan markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A, Growth

Focus Areas

Digital Health, Medtech, AI/ML

Geography

global, Bangladesh, and Taiwan

Investment Thesis

The firm believes technology can amplify and transform every aspect of healthcare to make it more accessible, higher quality, and more efficient. They invest primarily at early stages to back “transformative technology” that can “solve large unmet needs in health” and scale to reach millions, with the broader mission that “Healthtech is the key to extending healthspan for all.” They position themselves as active, operator-led partners who help founders cross from early to growth stage through hands-on expertise, network access, and portfolio collaboration.

Is Verge HealthTech Fund right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Verge HealthTech Fund is most relevant for founders raising Seed, Series A, and Growth rounds in Digital Health, Medtech, AI/ML, and Biotech, especially across global, Bangladesh, and Taiwan.

Focus statement

Stage- and sector-focused on Seed to Series A, geo-agnostic healthtech companies — especially AI & data analytics, next-gen diagnostics, breakthrough smart devices, digital health platforms, digital therapeutics, and healthcare SaaS; they prioritise "platforms that can reach millions" and technologies that address large unmet clinical and system needs.

Value Add

Operator-investor DNA: team described as "Experienced healthtech operators that actively partner with founders crossing the chasm from early to growth stage."
Active, hands-on approach — "Changemakers. Not just investors." (they emphasise partnering and active expertise rather than passive capital)
Global ecosystem access: portfolio companies get "Access to Verge’s global network of leading companies, investors, and institutions to help your company scale."
Portfolio synergies: they explicitly call out "Collaboration with our extended portfolio on R&D, commercial distribution, clinical trials, among others."
Stage specificity and geographic openness: explicit "Seed to Series A" focus and "Geo - Agnostic" mandate
Broad technical remit within healthtech — spanning AI, diagnostics, devices, digital therapeutics, platforms and healthcare SaaS (detailed categories are listed on the site).